Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
All content for MyeConversations by Myeloma Australia is the property of Myeloma Australia and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
S04 E20 - How myeloma impacts different body systems and strategies to keep people well on and off therapy
MyeConversations by Myeloma Australia
32 minutes
2 years ago
S04 E20 - How myeloma impacts different body systems and strategies to keep people well on and off therapy
In this episode Hayley Beer sits down with Donna Catamero, Nurse Practioner and Director of Myeloma Translational Research at The Mount Sinai in New York and member of the International Myeloma Foiundation Nurse Leadership Board. Hayley and Donna discuss how myeloma impacts different body systems and strategies keep people people well on and off therapy. Topics discussed include, bone, pain, kidneys, blood clots, peripheral neuropathy, GI, exercise, steriods, infections and travelling.
MyeConversations by Myeloma Australia
Part 2: Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma. This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.
